- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Minapharm Pharmaceuticals (MIPH)
Minapharm Pharmaceuticals stock price live, this page displays EGX MIPH stock exchange data. View the MIPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Minapharm Pharmaceuticals real time stock price chart below.
What Is the Minapharm Pharmaceuticals Stock Price Today?
The Minapharm Pharmaceuticals stock price today is 790.19.
What Is the Stock Symbol for Minapharm Pharmaceuticals?
The stock symbol for Minapharm Pharmaceuticals is "MIPH."
What Stock Exchange Does Minapharm Pharmaceuticals Trade On?
Minapharm Pharmaceuticals is listed and trades on the Egypt stock exchange.
Is Minapharm Pharmaceuticals a Good Stock to Buy?
Determining whether Minapharm Pharmaceuticals—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MIPH quote. (ISIN: EGS380G1C011)
What Is the Minapharm Pharmaceuticals Stock Price Today?
The Minapharm Pharmaceuticals stock price today is 790.19.
What Is the Stock Symbol for Minapharm Pharmaceuticals?
The stock symbol for Minapharm Pharmaceuticals is "MIPH."
What Stock Exchange Does Minapharm Pharmaceuticals Trade On?
Minapharm Pharmaceuticals is listed and trades on the Egypt stock exchange.
Is Minapharm Pharmaceuticals a Good Stock to Buy?
Determining whether Minapharm Pharmaceuticals—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MIPH quote. (ISIN: EGS380G1C011)
790.19
+27.36(+3.59%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
745.00
794.00
52 wk Range
232.01
831.00
MIPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
745.00794.00
52 wk Range
232.01831.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MIPH Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
Jun 10, 2026
EPS / Forecast
0.01 / --
Revenue / Forecast
1.6B / --
Compare MIPH to Peers and Sector
Metrics to compare | MIPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMIPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 28.5x | 15.6x | −0.3x | |
PEG Ratio | 0.30 | 0.10 | 0.00 | |
Price/Book | 1.4x | 3.7x | 2.6x | |
Price / LTM Sales | 1.4x | 2.8x | 3.1x | |
Upside (Analyst Target) | - | 22.3% | 47.6% | |
Fair Value Upside | Unlock | −7.3% | 5.6% | Unlock |
MINAPHARM Pharmaceuticals produces medicines, chemicals, cosmetics, veterinary medical products, medical and dental supplies, nutritional supplements, and herbal medicines in Egypt and internationally. It operates through Bio-production, Drug production, and Other products. The company provides its products for the treatment of acne, alopecia, analgesics and anti-inflammation, atopic dermatitis, autoimmune disease, bone health, cardiovascular, cerebral insufficiency, diabetic neuropathy and retinopathy, dyslipidemia, gastroenterology and hepatology, glaucoma, hematoma and thrombosis, hemorrhoids, haemostasis, immuno-stimulants and immunomodulatory, and infertility, as well as for iron deficiency anemia, Ischemia, labour induction, menopause, nausea and vomiting, ocular infection and inflammation, osteoporosis, peripheral arterial, post operative management, pregnancy and lacation, probiotic and gut health, psoriasis, respiratory tract infection, rheumatoid arthritis, supplements, topical antibiotics, topical muscle relaxant, and venous disease. MINAPHARM Pharmaceuticals was founded in 1958 and is headquartered in Cairo, Egypt.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Minapharm Pharma (MIPH) Stock Price Today?
The Minapharm Pharma stock price today is 790.19 EGP.
What Stock Exchange Does Minapharm Pharma Trade On?
Minapharm Pharma is listed and trades on the Egypt Stock Exchange.
What Is the Stock Symbol for Minapharm Pharma?
The stock symbol for Minapharm Pharma is "MIPH."
Does Minapharm Pharma Pay Dividends? What’s The Current Dividend Yield?
The Minapharm Pharma dividend yield is 0.32%.
What Is the Minapharm Pharma Market Cap?
As of today, Minapharm Pharma market cap is 9.31B EGP.
What Is Minapharm Pharma's Earnings Per Share (TTM)?
The Minapharm Pharma EPS (TTM) is 28.52.
From a Technical Analysis Perspective, Is MIPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Minapharm Pharma Stock Split?
Minapharm Pharma has split 3 times.
What is the current trading status of Minapharm Pharma (MIPH)?
As of Aug 21, 2026, Minapharm Pharma (MIPH) is trading at a price of 790.19 EGP, with a previous close of 762.83 EGP. The stock has fluctuated within a day range of 745.00 EGP to 794.00 EGP, while its 52-week range spans from 232.01 EGP to 831.00 EGP.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.